9.85 USD
+0.28
2.93%
At close Updated Nov 11, 4:00 PM EST
Pre-market
After hours
9.85
0.00
0%
1 day
2.93%
5 days
6.14%
1 month
8.48%
3 months
4.01%
6 months
-8.03%
Year to date
4.34%
1 year
3.58%
5 years
31.33%
10 years
31.33%
 

About: Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Employees: 24,622

0
Funds holding %
of 7,512 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™